BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
NIMIUM and Paraza partner to develop G3PP activators to treat cardiometabolic diseases
July 21, 2021
Synlogic begins phase I study of SYNB-1934 for phenylketonuria
July 16, 2021
New carboxylic acids synthesized at Prometic Pharma SMT
July 15, 2021
TP-03 enhances the stimulating effect of hCG on testicular steroidogenesis
July 14, 2021
ALG2-CDG model in zebrafish displays human phenotypes and hypo-N-glycosylation
July 13, 2021
NTLA-2001 decreases serum TTR protein concentrations through targeted knockout of TTR
July 12, 2021
Rare coding variant increases risk of Y chromosome loss, diabetes
July 12, 2021
Eli Lilly initiates phase I study of LY-3819469
July 12, 2021
Shire Human Genetic Therapies describes IDS gene therapy
July 12, 2021
YH-34160 leads to potent and sustained body weight loss in DIO mouse model
July 9, 2021
Previous
1
2
…
115
116
117
118
119
120
121
122
123
…
1798
1799
Next